![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 277/56 | |
A61K 31/426 | |||
A61P 19/06 |
(11) | Number of the document | 2398784 |
(13) | Kind of document | T |
(96) | European patent application number | 10724664.7 |
Date of filing the European patent application | 2010-06-10 | |
(97) | Date of publication of the European application | 2011-12-28 |
(45) | Date of publication and mention of the grant of the patent | 2012-10-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/038143 |
Date | 2010-06-10 |
(87) | Number | WO 2010/144685 |
Date | 2010-12-16 |
(30) | Number | Date | Country code |
185775 P | 2009-06-10 | US | |
222583 P | 2009-07-02 | US | |
233552 P | 2009-08-13 | US | |
235481 P | 2009-08-20 | US |
(72) |
PIRAN, Maytal, IL
METSGER, Leonid, IL
|
(73) |
Teva Pharmaceutical Industries Ltd. ,
124 Dvora HaNevi'a St., Tel Aviv 6944020,
IL
|
(54) | CRYSTALLINE FORMS OF FEBUXOSTAT |
CRYSTALLINE FORMS OF FEBUXOSTAT |